Literature DB >> 19106513

[A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy].

Kazuhisa Tokunou1, Shigeru Takeda, Shigefumi Yoshino, Taku Nishimura, Masaaki Oka.   

Abstract

We report here a case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy. A 57- year-old man received esophagectomy for advanced esophageal cancer. CT study revealed multiple lymphnode metastases, multiple bone metastases and multiple lung metastases after 15 months from the operation. So, chemotherapy was performed for the patient. Eleven days following the administration of docetaxel: 30 mg/m2 and nedaplatin: 30 mg/m2, the patient developed TLS (serum creatinine: 8.57 mg/dL, uric acid: 11.0 mg/dL, serum potassium: 6.3 mEq/L, serum phosphorus: 7.18 mg/dL). The patient responded well to an appropriate treatment with a combination of vigorous intravenous hydration, carperitide, allpurinol and potassium citrate sodium citrate. This case report describes the first patient to develop TLS following chemotherapy for esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106513

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Case report of recurrent spontaneous tumor lysis syndrome in a patient with esophageal cancer recovered via chemotherapy.

Authors:  Sho Watanabe; Ittoku Nanke; Kozue Uchidate; Tomoyo Machida; Akira Igarashi; Kenichiro Kobashi; Mariko Negi; Tsunehito Yauchi
Journal:  Int Cancer Conf J       Date:  2022-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.